Milton Pediatrics Opening at 9am Tuesday December 3, 2019
Due to inclement weather and for the safety of our patients and employees, Milton Pediatrics will delay opening until 9 am this morning. Be safe.
Meet our Newest Provider – Natan Seidel, MD
Dr. Natan Seidel is thrilled to start working at Milton Pediatrics! Dr. Seidel grew up in Washington, DC before studying biology in between a cappella practices at the University of North Carolina. (Go Heels!) He received his MD from Emory University School of Medicine, where he was elected to the Alpha Omega Alpha Medical Honor Society. Dr. Seidel completed his pediatric residency at Boston Children’s Hospital and Boston Medical Center (2018), and worked afterwards as an urgent care physician at Boston Children’s Emergency Department. He is certified by the American Board of Pediatrics in general pediatrics.
In his spare time, Dr. Seidel enjoys cooking, baking, swimming, disc golf, and playing guitar/piano. He lives in Jamaica Plain with his wife Sheila, an electrical engineer. Despite pressure from parents, they are currently kidless!
Adult, Child, & Infant CPR Course Tuesday January 28, 2020
We will be hosting an Adult, Child, & Infant CPR Course at 6pm in our Braintree Office. This course is through the American Heart Association and Certification is valid for 2 years. The cost is $50/pp. If you will be in the office before then, the sign up sheet is at the front desk. If not, feel free to call us at 781-356-6200 to register. You will receive a confirmation email once you are added to the roster.
All Infant Inclined Sleep Products Should Be Recalled, Consumer Reports Says
A new study confirms that all inclined infant sleepers pose risks to babies, prompting Consumer Reports to recommend that all of the products be banned.
2019 Flu Clinic Information
We have opened up the following Flu clinics for the 2019-2020 flu season. The Flu vaccine will be administered by appointment only. Please call 781-356-6200 during regular business hours to schedule an appointment. Be aware that these days may fill up and we will offer additional dates in the near future. Updated 11/27/19
Wednesday Oct 2nd 12-5
Monday Oct 7th 5-7 pm
Thursday Oct 10th 12-5
Wednesday Oct 16th 5-7 pm
Sunday Oct 20th 9-12
Tuesday Oct 22nd 9-1 & 2-5
Wednesday Oct 23rd 9-1 & 2-5
Thursday Oct 24th 12-5
Friday Oct 25th 9-1 & 2-5
Saturday Oct 26th 9-12
Sunday Oct 27th 9-12
Tuesday Nov 5th 9-1 & 2-5
Wednesday Nov 6th 9-1 & 2-5
Saturday Nov 9th 9-12
Thursday Nov 14th 9-1 & 2-5
Thursday Nov 21st 9-1
Saturday Nov 23rd 9-12
Tuesday Nov 26th 9-1 & 2-5
Wednesday Nov 27th 9-1
Monday Dec 23 9-1 & 1:30-3
School and Health Forms
May 10, 2019
As the time of the year approaches for school and health forms we ask that you request these forms as far in advance as possible. Please allow up to 5 business days for completion.
Due to the high demand we are unable to process these requests the same day. Once you receive your forms please make several copies for your record.
Thank you.
Milton Pediatrics.
Recall Alert:Fisher Price Rock ‘n Play Sleeper
Serious safety concerns about the Fisher-Price Rock ‘n Play Sleeper. The Amerian Academy of Pediatrics has requested that the U.S. Consumer Product Safety Commisison issue an immediate recall of this device due to reports of infant deaths. If you are using this sleeper, we recommend finding an alternative sleep solution. Please navigate to the following links for more information. If you have any questions please call our office: 781-356-6200 and speak with one of our nurses.
Fisher-Price has recalled the Rock ‘n Play sleeper. You should stop using this sleeper immediately. Please see below for more information:
https://www.cpsc.gov/Recalls/2019/fisher-price-recalls-rock-n-play-sleepers-due-to-reports-of-deaths
| Fisher-Price Recalls Rock ‘n Play Sleepers Due to Reports of Deaths | CPSC.govwww.cpsc.govSince the 2009 product introduction, over 30 infant fatalities have occurred in Rock ‘n Play Sleepers, after the infants rolled over while unrestrained, or under other circumstances. The U.S. Consumer Product Safety Commission is charged with protecting the public from unreasonable risks of injury … |
Milton Pediatrics.
Measles Information
If you have questions about the case of Measles reported in the local media, please refer to the following links provided by the State Department of Public health:
- Information about the specific case: https://www.mass.gov/news/state-health-officials-alert-residents-about-potential-exposure-to-measles-in-multiple
- General information about Measles: https://www.mass.gov/service-details/measles
If you are concerned that your child may have been exposed to the patient, please contact our office: 781-356-6200
Milton Pediatrics
Monday 3/4/2019
Due to the storm, our call hour will be pushed from 7 am to 9 am. today 3/4/19 We will be open for business beginning at 9 am today.
Thank you.
Milton Pediatrics
Lactation Support Program
Milton Pediatrics
2018 Seasonal Flu Vaccine
Seasonal Flu Vaccine is now available in our office, please call 781-356-6200 for your appointment.
Thank you,
Milton Pediatrics
New Live Calls
On Tuesday, May 1st Milton Pediatrics will be transitioning to a new phone system. Our nurses will now be answering live calls from a queue system and you will no longer need to leave a voicemail for a callback. The live calls will begin at 9a until 5 pm.
Between the hours of 7a-8a, we will have our call hour where there you will leave a message and one of our nurses will call back. Between the hours of 8a-9a, you will be connected to our after-hours answering service.
Flu and Other Vaccinations
For all of our patients planning to receive the flu (or any other) vaccination, it is strongly recommended that patients come to Milton Pediatrics for vaccination accompanied by another person, ideally a parent/guardian.
If patients under 18 years of age arrive to Milton Pediatrics for vaccination without a parent/guardian, this person will be called in order to receive permission to administer the vaccination.
In addition, if any patient of driving age arrives alone for vaccination he/she will be asked to remain an additional 15 minutes to be monitored for any adverse symptoms or reactions.
Transition to Partners eCare
We would like to thank you for your patience while we upgrade to Partners eCare, our new electronic medical record system.
Our staff has undergone extensive training and we have made every effort to ensure that there is minimal impact to you during this transition. This system is still new to us and we apologize for any inconvenience you may experience.
Our first priority, as always, is to deliver the highest quality care possible. If you have any questions about Partners eCare, or your experience during today’s visit, please let any staff member know and we will be happy to assist you.
Thank you – your help makes the difference.
Hyland’s Teething Tablets Recalled
The maker of Hyland’s Teething Tablets, previously removed from the market due to inconsistent levels of potentially toxic substances, has now issued a recall for all remaining packages. Please see further information here: https://www.fda.gov/Safety/Recalls/ucm552934.htm.
Worldwide Recall of EpiPen® Auto-Injector
Mylan N.V. (NASDAQ, TASE: MYL) today announced that Meridian Medical Technologies, a Pfizer company and Mylan’s manufacturing partner for EpiPen® Auto-Injector, has expanded a voluntary recall of select lots of EpiPen (epinephrine injection, USP) and EpiPen Jr® (epinephrine injection, USP) Auto-Injectors to now include additional lots distributed in the U.S. and other markets in consultation with the U.S. Food and Drug Administration (FDA).
This recall is being conducted as a result of the receipt of two previously disclosed reports outside of the U.S. of failure to activate the device due to a potential defect in a supplier component. The potential defect could make the device difficult to activate in an emergency (failure to activate or increased force needed to activate) and have significant health consequences for a patient experiencing a life-threatening allergic reaction (anaphylaxis). Both reports are related to the single lot that was previously recalled. The incidence of the defect is extremely rare and testing and analysis across the potentially impacted lots has not identified any units with a defect. However, the recall is being expanded to include additional lots as a precautionary measure out of an abundance of caution.
The recalled product was manufactured by Meridian Medical Technologies, a Pfizer company, and distributed by Mylan Specialty between December 2015 and July 2016. The expanded voluntary recall is being initiated in the U.S. and also will extend to additional markets in Europe, Asia, North and South America.
The recall impacts the 0.3 mg and 0.15 mg strengths of EpiPen Auto-Injector. None of the recalled lots include the authorized generic for EpiPen Auto-Injector, which is also manufactured by Meridian Medical Technologies.
U.S. Impacted Lots:
| Product/Dosage | NDC Number | Lot Number | Expiration Date |
|---|---|---|---|
| EpiPen Jr 2-Pak® Auto-Injectors, 0.15 mg | 49502-501-02 | 5GN767 | April 2017 |
| EpiPen Jr 2-Pak® Auto-Injectors, 0.15 mg | 49502-501-02 | 5GN773 | April 2017 |
| EpiPen 2-Pak® Auto-Injectors, 0.3 mg | 49502-500-02 | 5GM631 | April 2017 |
| EpiPen 2-Pak® Auto-Injectors, 0.3 mg | 49502-500-02 | 5GM640 | May 2017 |
| EpiPen Jr 2-Pak® Auto-Injectors, 0.15 mg | 49502-501-02 | 6GN215 | September 2017 |
| EpiPen 2-Pak® Auto-Injectors, 0.3 mg | 49502-500-02 | 6GM082 | September 2017 |
| EpiPen 2-Pak® Auto-Injectors, 0.3 mg | 49502-500-02 | 6GM072 | September 2017 |
| EpiPen 2-Pak® Auto-Injectors, 0.3 mg | 49502-500-02 | 6GM081 | September 2017 |
| EpiPen 2-Pak® Auto-Injectors, 0.3 mg | 49502-500-02 | 6GM088 | October 2017 |
| EpiPen 2-Pak® Auto-Injectors, 0.3 mg | 49502-500-02 | 6GM199 | October 2017 |
| EpiPen 2-Pak® Auto-Injectors, 0.3 mg | 49502-500-02 | 6GM091 | October 2017 |
| EpiPen 2-Pak® Auto-Injectors, 0.3 mg | 49502-500-02 | 6GM198 | October 2017 |
| EpiPen 2-pak® Auto-Injectors, 0.3 mg | 49502-500-02 | 6GM087 | October 2017 |
Mylan is committed to replacing recalled devices at no cost and Mylan would like to reassure patients that there will be no additional replacement-related financial burden to them as a result of this recall. Patients, customers and distributors are being notified and should refer to Mylan.com/EpiPenRecall for updates on product return and replacement instructions. We are asking patients to keep their existing product until their replacement product can be secured.
Patients may receive either EpiPen Auto-Injector or the authorized generic for EpiPen Auto-Injector at the pharmacy as a replacement based on availability. The authorized generic has the exact same drug formulation, has the exact same operating instructions and is therapeutically equivalent to EpiPen Auto Injector, and may be substituted for EpiPen Auto Injector.
It is important that patients continue to carry their current EpiPen Auto-Injector until they receive a replacement device.
To return your product please contact Stericycle at 877-650-3494. If you have any additional questions regarding this recall, please contact Mylan Customer Relations at 800-796-9526 or customer.service@mylan.com.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
- Complete and submit the report Online: www.fda.gov/medwatch/report.htm
- Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.
This voluntary recall is being conducted with the knowledge of FDA.
Epinephrine is the first-line treatment for a life-threatening allergic reaction (anaphylaxis) and access to this product is critical in the event of an emergency. Delays in epinephrine administration have been associated with negative health consequences.
More information about the risks and benefits of EpiPen® Auto-Injector can be found at EpiPen.com.
Please see the full Prescribing Information and Patient Information.
Phones and Systems Back up!
Dear Patients,
Our Phones and systems are now working. When calling the offices please use the contact phone numbers for the corresponding office. The temporary email used yesterday is no longer in service and it is not monitored please discontinue using this method to reach out to us.
Thank you all so much for your patience and understanding during yesterdays outage.
Milton Pediatrics.
Phone and Systems outage
We are experiencing phone and systems outages in our Braintree office.
Please call 617-724-0924 for any after hours questions, or concerns regarding your child/ren.
Please do not email us using the email we had stated earlier, that email is not monitored after hours.
Please call 911 with any life-threatening concerns.
We apologize for any inconvenience this may cause.
Office closed – Tuesday March 14, 2017
Due to the inclement weather, our office will be closed on Tuesday March 14, 2017.